Worth Venture Partners, LLC Sc Pharmaceuticals Inc. Transaction History

Worth Venture Partners, LLC

$34.6 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.86 - $6.39 $3.74 Million - $4.91 Million	-769,061 Reduced 99.7%	2,283 $11,000
Q4 2023 Feb 09, 2024	BUY	$4.7 - $6.63 $1.09 Million - $1.54 Million	231,679 Added 42.93%	771,344 $4.84 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $9.82 $191,296 - $268,360	27,328 Added 5.33%	539,665 $3.84 Million
Q2 2023 Aug 14, 2023	BUY	$8.94 - $11.74 $15,099 - $19,828	1,689 Added 0.33%	512,337 $5.22 Million
Q1 2023 May 15, 2023	SELL	$5.59 - $9.47 $652,380 - $1.11 Million	-116,705 Reduced 18.6%	510,648 $4.63 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $1.76 Million - $3.3 Million	438,831 Added 232.77%	627,353 $4.5 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $660,634 - $961,458	-147,463 Reduced 43.89%	188,522 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$4.3 - $6.48 $53,492 - $80,611	-12,440 Reduced 3.57%	335,985 $1.78 Million
Q1 2022 May 16, 2022	BUY	$3.9 - $6.11 $61,534 - $96,403	15,778 Added 4.74%	348,425 $1.98 Million
Q4 2021 Feb 14, 2022	BUY	$3.88 - $6.9 $123,721 - $220,020	31,887 Added 10.6%	332,647 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$4.93 - $7.15 $674,256 - $977,876	136,766 Added 83.4%	300,760 $2 Million
Q2 2021 Aug 16, 2021	SELL	$5.19 - $7.38 $259,842 - $369,487	-50,066 Reduced 23.39%	163,994 $1 Million
Q1 2021 May 17, 2021	BUY	$5.65 - $7.66 $289,195 - $392,077	51,185 Added 31.43%	214,060 $1.42 Million
Q4 2020 Feb 17, 2021	SELL	$5.17 - $9.41 $65,405 - $119,045	-12,651 Reduced 7.21%	162,875 $862,000
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $223,478 - $349,404	31,880 Added 22.19%	175,526 $1.29 Million
Q1 2020 May 15, 2020	BUY	$5.4 - $10.45 $103,361 - $200,023	19,141 Added 15.37%	143,646 $1.06 Million
Q4 2019 Feb 14, 2020	BUY	$4.1 - $6.21 $510,470 - $773,176	124,505 New	124,505 $704,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

Orbimed Advisors LLC San Diego, CA

6.06M
Shares

$20.5 Million
0.65% of portfolio
Rubric Capital Management LP New York, NY

4.78M
Shares

$16.2 Million
0.61% of portfolio
Aigh Capital Management LLC Baltimore, MD

4.12M
Shares

$14 Million
7.6% of portfolio
King Luther Capital Management Corp Fort Worth, TX

2.23M
Shares

$7.55 Million
0.04% of portfolio
Suvretta Capital Management, LLC New York, NY

2.05M
Shares

$6.95 Million
0.37% of portfolio

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Account